Annual General Meeting of Q-Med AB (publ).STOCKHOLM, Sweden -- The Board of Directors of Q-Med AB (publ) (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :QMED) has of today published a notice to attend the Annual General Meeting, which will be held on Wednesday May 3 at 3 p.m. on Q-Med's premises. Entrance from Fyrisvallsgatan 7, Uppsala, Sweden. A notice has been published in Upsala Nya Tidning Upsala Nya Tidning or UNT is a regional daily newspaper published in Uppsala (older spelling Upsala), Sweden. The name means Upsala New Newspaper and the first issue appeared in 1890. It has a circulation of about 60,000 (in 2003). , Svenska Dagbladet and in Post- och Inrikes Tidningar Post- och Inrikes Tidningar or PoIT (Swedish for "Post and Domestic Newspaper") is the government newspaper and gazette of Sweden, and the country's official notification medium for announcements like bankruptcy declarations or auctions. (Swedish Offical Gazette). The complete notice of the Annual General Meeting in English can be found on the corporate web site www.q-med.com, and is also attached. Q-Med AB (publ) The Board In the US, Q-Med AB's affiliate is the wholly-owned subsidiary Q-Med Scandinavia, Inc. Q-Med AB (publ), Seminariegatan 21, SE-752 28 Uppsala, Tel: 018-474 90 00, Fax: 018-474 90 01 info@q-med.com, www.q-med.com, Org.nr. 556258-6882 Q-Med is a rapidly growing and profitable medical device company. The company develops, produces, markets and sells implants for esthetic and medical use. All products are based on the company's patented NASHA NASHA Non-Animal, Stabilized Hyaluronic Acid (trademark of Q-Med AB; Uppsala, Sweden) NASHA National Association for Speech and Hearing Action (Rockville, MD) technology - Non-Animal Stabilized Hyaluronic Acid. The product portfolio today contains: RESTYLANE for the filling out of lips and facial wrinkles and for facial contouring, DUROLANE, for the treatment of osteoarthritis of the hip and knee joints, DEFLUX for the treatment of vesicoureteral reflux (a malformation malformation /mal·for·ma·tion/ (-for-ma´shun) 1. a type of anomaly. 2. a morphologic defect of an organ or larger region of the body, resulting from an intrinsically abnormal developmental process. of the urinary bladder) in children and ZUIDEX, for the treatment of stress urinary incontinence stress urinary incontinence n. See stress incontinence. in women. Sales are made through the company's own subsidiaries or distributors in over 70 countries. Q-Med today has just over 550 co-workers, with approximately 350 at the company's head office and production facility in Uppsala. The Q-Med share is listed on the O-list of the Stockholm Stock Exchange The Stockholm Stock Exchange (Swedish: Stockholmsbörsen) is a stock exchange located in Stockholm, Sweden. Founded in 1863 [1] it is the primary securities exchange of the Nordic Countries. . NASHA, DUROLANE, ZUIDEX, IMPLACER, DEFLUX and all product names within the RESTYLANE family are trademarks that belong to Q-Med. This information was brought to you by Waymaker http://www.waymaker.net |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion